Abstract
The key finding of this study is that stenotic peripheral arteriovenous fistulas (AVF) lesions treated with drug-coated balloon angioplasty (DCB) had a significant improvement in the 6-month and 12-month primary patency rates when compared with those lesions treated with conventional balloon angioplasty.1 Treatment of central venous stenosis was also significantly improved with DCB, although this is more controversial because there are no large diameter drug-coated balloons (10-14 mm) that are approved in the United States.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
